Defining the Optimal Therapy Sequence in Synchronous Resectable Liver Metastases from Colorectal Cancer: A Decision Analysis Approach

References

• Cancer Incidence in Belgium 2004–2005. Belgian Cancer Registry, 2008: 44–48.
   Google Scholar
• Leporrier J., Maurel J., Chiche L., Bara S., Segol P., Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg, 2006, 93: 465–474.
   Google Scholar
• Fahy B. N., D’Angelica M., DeMatteo R. P., Blumgart L. H., Weiser M. R., Ostrovnaya I., Gonen M., Jarnagin W. R. Synchronous Hepatic Metastases from Colon Cancer: Changing Treatment Strategies and Results of Surgical Intervention. Ann Surg Oncol, 2009, 16: 361–370.
   Google Scholar
• Konopke R., Kersting S., Distler M., Dietrich J., Gastmeier J., Heller A., Kulisch E., Saeger H. D. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int, 2009, 29: 89–102.
   Google Scholar
• Hillingso J. G., Wille-Jorgensen P. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer-a systematic review. Colorectal Dis, 2009, 11: 3–10.
   Google Scholar
• Law W. L., Choi H. K., Lee Y. M., Ho J. W. C. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol, 2007, 14: 25592566.
   Google Scholar
• Demicheli R., Retsky M. W., Hrushesky W. J. M., Baum M., Gukas I. D. The effects of surgery on tumor growth: a century of investigations. Annals of Oncology, 2008, 19: 1821–1828.
   Google Scholar
• Peeters C., de Waal R. M. W., Wobbes T., Ruers T. J. M. Metastatic Dormancy Imposed by the Primary Tumor: Does it Exist in Humans ? Ann Surg Oncol, 2008, 15: 3308–3315.
   Google Scholar
• Oreilly M. S., Holmgren L., Shing Y., Chen C., Rosenthal R. A., Moses M., Lane W. S., Cao Y. H., Sage E. H., Folkman J. Angiostatin-a Novel Angiogenesis Inhibitor That Mediates the Suppression of Metastases by a Lewis Lung-Carcinoma. Cell, 1994, 79: 315–328.
   Google Scholar
• OReilly M. S., Holmgren L., Chen C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med, 1996, 2: 689–692.
   Google Scholar
• Scheer M. G. W., Stollman T. H., Vogel W. V., Boerman O. C., Oyen W. J. G., Ruers T. J. M. Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor. J Nucl Med, 2008, 49: 887–891.
   Google Scholar
• Peeters C. F. J. M., Westphal J. R., De Waal R. M. W., Ruiter D. J., Wobbes T., Ruers T. J. M. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer, 2004, 112: 554–559.
   Google Scholar
• Peeters C. F. J. M., De Waal R. M. W., Wobbes T., Westphal J. R., Ruers T. J. M. Outgrowth of human liver metastases after resection of the primary colorectal tumor: A shift in the balance between apoptosis and proliferation. Int J Cancer, 2006, 119: 1249–1253.
   Google Scholar
• Birkmeyer J., Birkmeyer N. Decision analysis in surgery. Surgery, 1996, 120: 7–15.
   Google Scholar
• Manns B. J. The role of health economics within clinical research. Methods Mol Biol, 2009, 473: 235–50.
   Google Scholar
• Mentha G., Roth A. D., Terraz S., Giostra E., Gervaz P., Andres A., Morel P., Rubbia-Brandt L., Majno P. E. ‘Liver First’ Approach in the Treatment of Colorectal Cancer with Synchronous Liver Metastases. Dig Surg, 2008, 25: 430–435.
   Google Scholar
• Mentha G., Majno P. E., Andres A., Rubbia-Brandt L., Morel P., Roth A. D. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg, 2006, 93: 872–878.
   Google Scholar
• Mortenson M. M., Curley S. A., Vauthey J. N., Beaty K., Abdalla E. K. Resection of hepatic metastases before the colorectal primary: An alternate treatment strategy for synchronous disease. Ann Surg Oncol, 2008, 15: 55–56.
   Google Scholar
• Scoggins C. R., Campbell M. L., Landry C. S., Slomiany B. A., Woodall C. E., McMasters K. M., Martin R. C. G. Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of Hepatic Resection for Colorectal Cancer Metastases. Ann Surg Oncol, 2009, 16: 35–41.
   Google Scholar
• Saltz L. B., Clarke S., Diaz-Rubio E., Scheithauer W., Figer A., Wong R., Koski S., Lichinitser M., Yang T. S., Rivera F., Couture F., Sirzen F., Cassidy J. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study. J Clin Oncol, 2008, 26: 2013–2019.
   Google Scholar
• Scheer M. G. W., Sloots C. E. J., van der Wilt G. J., Ruers T. J. M. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol, 2008, 19: 1829–1835.
   Google Scholar
• Reddy S. K., Pawlik T. M., Zorzi D., Gleisner A. L., Ribero D., Assumpcao L., Barbas A. S., Abdalla E. K., Choti M. A., Vauthey J. N., Ludwig K. A., Mantyh C. R., Morse M. A., Clary B. M. Simultaneous resections of colorectal cancer and synchronous liver metastases: A multi-institutional analysis. Ann Surg Oncol, 2007, 14: 3481–3491.
   Google Scholar
• Gazelle G. S., Hunink M. G. M., Kuntz K. M., McMahon P. M., Halpern E. F., Beinfeld M., Lester J. S., Tanabe K. K., Weinstein M. C. Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma-A state-transition Monte Carlo decision analysis. Ann Surg, 2003, 237: 544–555.
   Google Scholar
• Langenhoff B. S., Krabbe P. F. M., Ruers T. J. M. Computer-based decision making in medicine: A model for surgery of colorectal liver metastases. Eur J Surg Oncol, 2007, 33: S111–S117.
   Google Scholar
• Aloia T. A., Fahy B. N. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases. Clin Colorectal Cancer, 2008, 7: 197–201.
   Google Scholar